2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow efaproxiral: new trials by email Literature Review of efaproxiral trials Research Report on efaproxiral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma carmustine, efaproxiral - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | New Approaches to Brain Tumor Therapy Consortium | 48 | 2000-07-01 | 2013-06-21 |
| Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer carboplatin, chemotherapy, efaproxiral - Lung Cancer | Phase 2 | Completed | Spectrum Pharmaceuticals, Inc | 1998-10-01 | 2021-08-26 |
Astrocytoma (1) · Brain Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Gliosarcoma (1) · Lung Neoplasms (1) · Oligodendroglioma (1)
New Approaches to Brain Tumor Therapy Consortium (1) · Spectrum Pharmaceuticals, Inc (1)
United States (2) · Canada (1)
Hak Choy, MD (1) · Pamela Z. New, MD (1)